Metabolic surgery may protect against admission for COVID-19 in persons with nonalcoholic fatty liver disease

BACKGROUND: SARS-CoV-2 (COVID-19) disease causes significant morbidity and mortality through increased inflammation and thrombosis. Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are states of chronic inflammation and indicate advanced metabolic disease. OBJECTIVE:...

Descripción completa

Detalles Bibliográficos
Autores principales: Tignanelli, Christopher J., Bramante, Carolyn T., Dutta, Nirjhar, Tamariz, Leonardo, Usher, Michael G., Ikramuddin, Sayeed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. on behalf of American Society for Bariatric Surgery. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238640/
https://www.ncbi.nlm.nih.gov/pubmed/34326020
http://dx.doi.org/10.1016/j.soard.2021.05.029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238640/
https://www.ncbi.nlm.nih.gov/pubmed/34326020
http://dx.doi.org/10.1016/j.soard.2021.05.029

Ejemplares similares